Oral Lactobacillus Crispatus Lc-G22 as Adjunctive Therapy for Vulvovaginal Candidiasis
NCT07727967
·
clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
100
Enrollment
INDUSTRY
Sponsor class
Conditions
Vulvovaginal Candidiasis
Interventions
DIETARY_SUPPLEMENT:
Lactobacillus crispatus Lc-G22
DIETARY_SUPPLEMENT:
Placebo
Sponsor
BioGrowing Co., Ltd